SB-T-1214, CAS [[178250-23-2]] Preis auf Anfrage

Artikelnummer: TGM-T210736
Artikelname: SB-T-1214, CAS [[178250-23-2]] Preis auf Anfrage
Artikelnummer: TGM-T210736
Hersteller Artikelnummer: T210736
Alternativnummer: TGM-T210736-10MG,TGM-T210736-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
SB-T-1214 (SBT) is a taxane-based drug known for its ability to effectively suppress the expression of stem cell-related genes (Oct4, Sox2, and c-Myc) and induce apoptosis in drug-resistant tumorigenic CD133+/CD44+ colon cancer spheroids. In Pgp+ DLD-1 human colon tumor xenograft mouse models, SB-T-1214 successfully inhibits tumor growth. This compound is relevant for anti-tumor research, particularly against drug-resistant tumors such as colon, pancreatic, and renal cancers.
Molekulargewicht: 853.95
CAS Nummer: [178250-23-2]
Formel: C45H59NO15
Target-Kategorie: OCT|||Apoptosis|||c-Myc
T210736